Evidence map›Paper›PMID 38551167›Full record

ArticleJournal of the American Chemical Society2024

Rapid and Modular Access to Multifunctionalized 1,2-Azaborines via Palladium/Norbornene Cooperative Catalysis.

Shinyoung Choi, Guangbin Dong

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. A Catalyst-Controlled Divergent Rearomatization of BN-Benzvalene.Journal of the American Chemical Society · 2026
    Article
  5. Article
  6. Positional Isomerization of 1,2-Azaborine through BN-Benzvalene.Journal of the American Chemical Society · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Switchable Site-Selective Benzanilide C(spMolecules (Basel, Switzerland) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Shinyoung ChoiDepartment of Chemistry, University of Chicago, Chicago, Illinois 60637, United States.
Guangbin DongDepartment of Chemistry, University of Chicago, Chicago, Illinois 60637, United States.ORCID 0000-0003-1331-6015

Funding

New Directions in Palladium/Norbornene Cooperative-RenewalR01GM124414 · NIGMS · UNIVERSITY OF CHICAGO · PI DONG, GUANGBIN · 2018 to 2025
$2.6M
Modular Synthesis of 1,2-Azaborines via Boron-mediated Strain-release Reductive CyclizationR21GM144048 · NIGMS · UNIVERSITY OF CHICAGO · PI DONG, GUANGBIN · 2021 to 2022
$451k
NIGMS NIH HHS R01 GM124414NIGMS NIH HHS R21 GM144048
6 · The paper itself

Abstract

1,2-Azaborines, a unique class of BN-isosteres of benzene, have attracted great interest across several fields. While significant advancements have been made in the postfunctionalization of 1,2-azaborines, challenges still exist for the selective functionalization of the C4 position and access to 1,2-azaborines with five or six independently installed substituents. Here we report a rapid and modular method for C3 and C4 difunctionalization of 1,2-azaborines using the palladium/norbornene (Pd/NBE) cooperative catalysis. Enabled by the C2 amide-substituted NBE, diverse 3-iodo-1,2-azaborines can be used as substrates, showing broad functional group tolerance. Besides

Indexed as

Boron CompoundsPalladiumCatalysisNorbornanes1,2-azaborine2-norborneneBoron CompoundsNorbornanesPalladium

Identifiers

PMID38551167
PMCPMC11776437

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.